DrugDashboards

tenapanor

tenapanor · TENAPANOR 21.3 mg/1 · Tablet, Film Coated · Patheon Pharmaceuticals Inc.

NDC 67651-0380-00 · 48500 TABLET, FILM COATED in 1 DRUM · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of tenapanor (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Ardelyx, Inc.TENAPANOR HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Ardelyx, Inc.TENAPANOR HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Ardelyx, Inc.TENAPANOR HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Patheon Pharmaceuticals Inc.TENAPANOR 21.3 mg/1Jul 15, 2026Sep 2, 2026
Patheon Pharmaceuticals Inc.TENAPANOR 31.9 mg/1Jul 15, 2026Sep 2, 2026
Patheon Pharmaceuticals Inc.TENAPANOR HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "tenapanor — NDC 67651-0380-00," retrieved September 3, 2026, https://drugdashboards.com/drug/67651038000.

Free to cite with attribution — see how the data is put together.